Loading...

Brefeldin A Solution (1,000X)

Pricing & Availability
Regulatory Status
RUO
Other Names
BFA
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420601 1 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Concentration
5.0 mg/ml
Storage & Handling
Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature.
Application

ICFC - Quality tested
Recommended Usage

Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.

Application Notes

Completely thaw the solution before use, DMSO freezes at 4°C.  We recommend aliquotting the reagent into smaller volumes to avoid repeated freeze-thawing.  

Application References
  1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278.
  2. Fuse S, et al. 2007. J. Immunol. 178:5227.
  3. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  4. Redfern CH,et al.2006.J. Clin Oncol.19:3107. PubMed
  5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed
  6. Elzey BD, et al. 2008. Blood 111:38684. PubMed
  7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed
  8. Miner MD, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed
  10. Markey KA, et al. 2009. Blood 113:5644. PubMed
  11. Wilcox RA, et al. 2009. Blood PubMed
  12. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed
  13. Rozkova D, et al. 2009. Clin Immunol. 131:1. PubMed
  14. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065.
  15. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed
  16. Liu WC, et al. 2010. J. Virol. 84:12011.15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed
  17. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  18. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
  19. Langkjaer A, et al. 2012. Clin Immunol. 145:1. PubMed
  20. Molinero LL, et al. 2012. PNAS. 109:18529. PubMed
  21. Li HW, et al. 2012. J. Immunol. 189:5572. PubMed
  22. Wang JM, et al. 2013. J. Virol. 87:4372. PubMed
  23. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  24. Wang Jm, et al. 2013. J Virol. 87:11626. PubMed
  25. Lee TH, et al. 2013. J Biol Chem. 288:32873. PubMed
  26. Shi L, et al. 2014. J. Immunol. 192:649. PubMed
  27. Bulati M, et al. 2014. Exp Gerontol. PubMed
  28. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  29. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  30. Miller ML, et al. 2014. PNAS. 111:7397. PubMed
  31. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  32. Zhou GL, et al. 2014. J Cell Sci. 127:3916. PubMed
  33. Rist MJ, et al. 2015. J Virol. 89:703. PubMed
Product Citations
  1. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  2. Yakkala C, et al. 2021. Front Immunol. 12:695150. PubMed
  3. Zheng B, et al. 2021. Int J Mol Sci. 22: . PubMed
  4. Alexander KL, et al. 2021. Gastroenterology. 161:522. PubMed
  5. Trinks N, et al. 2021. Commun Biol. 4:1151. PubMed
  6. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  7. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  8. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  9. Persaud AT, et al. 2022. J Leukoc Biol. 111:573. PubMed
  10. Yu L, et al. 2022. FEBS J. 289:3241. PubMed
  11. Ritzel RM, et al. 2022. Geroscience. 44:1407. PubMed
  12. D'Angeli V, et al. 2022. Eur J Immunol. 52:1058. PubMed
  13. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  14. Kanbar JN, et al. 2022. J Exp Med. 219: . PubMed
  15. Minichino D, et al. 2022. J Leukoc Biol. 112:1089. PubMed
  16. Gao KM, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202327119. PubMed
  17. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  18. Jondle CN, et al. 2022. J Virol. 96:e0063922. PubMed
  19. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  20. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  21. Li FL, et al. 2022. EMBO J. 41:e110698. PubMed
  22. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  23. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  24. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  25. Shamriz O, et al. 2023. Front Immunol. 13:1044933. PubMed
  26. Chan L, et al. 2022. Cells. 12: . PubMed
  27. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  28. Nanishi E, et al. 2023. NPJ Vaccines. 8:18. PubMed
  29. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  30. Li Y, et al. 2022. Brain Behav Immun. 101:1. PubMed
  31. Zander R, et al. 2022. Immunity. 55:475. PubMed
  32. Pymm P, et al. 2022. Cell Rep. 38:110449. PubMed
  33. Giles JR, et al. 2022. Immunity. 55:557. PubMed
  34. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  35. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  36. Zhao Y, et al. 2022. ACS Appl Mater Interfaces. 14:21872. PubMed
  37. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  38. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  39. Redelman-Sidi G, et al. 2022. Cancer Immunol Res. 10:1241. PubMed
  40. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  41. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  42. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  43. Yang WL, et al. 2023. Nat Commun. 14:863. PubMed
  44. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  45. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  46. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  47. Mohammadpour H, et al. 2023. Cell Rep. 42:112250. PubMed
  48. Jung HY, et al. 2023. Oncoimmunology. 12:2190671. PubMed
  49. Li Y, et al. 2023. Vaccines (Basel). 11:. PubMed
  50. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  51. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  52. Ko ES, et al. 2023. Cell Commun Signal. 21:107. PubMed
  53. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  54. Thomas OG, et al. 2023. Sci Adv. 9:eadg3032. PubMed
  55. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  56. Adamo S, et al. 2023. Cell Host Microbe. 31:928. PubMed
  57. LaPorte KM, et al. 2023. J Immunother Cancer. 11:. PubMed
  58. Patskovsky Y, et al. 2023. Nat Commun. 14:3763. PubMed
  59. Wang R, et al. 2018. Oncoimmunology. 7:e1461303. PubMed
  60. Chen J, et al. 2022. Adv Healthc Mater. 11:e2101714. PubMed
  61. Aguilar-Pineda JA, et al. 2021. iScience. 24:102993. PubMed
  62. Moudra A, et al. 2021. J Immunol. 206:2109. PubMed
  63. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  64. Pablo-Bernal R, et al. 2016. J Gerontol A Biol Sci Med Sci. 71: 610 - 618. PubMed
  65. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  66. Zhu S, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.10.013. PubMed
  67. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  68. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  69. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  70. Nesterenko PA, et al. 2021. Cell Rep. 37:110167. PubMed
  71. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  72. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  73. Fote GM, et al. 2022. J Cell Sci. 135:. PubMed
  74. Weng RR, et al. 2021. Nat Commun. 12:2163. PubMed
  75. Yamamoto A, et al. 2019. J Clin Invest. 129:3640. PubMed
  76. Shi L, et al. 2014. J Immunol. 192:649. PubMed
  77. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  78. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  79. Gay MD, et al. 2020. Cancer Prev Res (Phila). . PubMed
  80. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  81. Just S, et al. 2016. Sci Rep. 6:39796. PubMed
  82. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  83. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  84. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  85. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  86. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  87. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  88. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  89. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  90. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  91. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  92. Nguyen K, et al. 2008. J Immunol. 181:5386. PubMed
  93. Wilcox R, et al. 2009. Blood. 114:2936. PubMed
  94. Starnbach X 2015. J Immunol. 195: 1665-1675. PubMed
  95. Garg B, et al. 2016. Mutagenesis. 10.1093/mutage/gew023. PubMed
  96. Ruhland M, et al. 2016. Nat Commun. 7:11762. PubMed
  97. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  98. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  99. Jondle CN, et al. 2021. MBio. 12:. PubMed
  100. Martens A, et al. 2020. Nat Immunol. 21:381. PubMed
  101. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  102. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  103. Hradilova N, et al. 2017. PLoS One. 12(2):e0171539. PubMed
  104. Smithey M, et al. 2008. J Immunol. 180:3406. PubMed
  105. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  106. Griffiths K, et al. 2016. Nat Commun. 7:13894. PubMed
  107. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  108. Al-Attar A, et al. 2016. Data Brief. 8: 536-44. PubMed
  109. Gonzalez-Perez G, et al. 2016. J Immunol. 196: 3768 - 3779. PubMed
  110. Pablo-Bernal R, et al. 2015. J Infect Dis. 10.1093/infdis/jiv520. PubMed
  111. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  112. Kang X, et al. 2022. Vaccines (Basel). 10:. PubMed
  113. Dayoub O, et al. 2017. Sci Rep. 10.1038/s41598-017-09933-4. PubMed
  114. Douthwaite J, et al. 2017. J Immunol. 198(1):528-537. PubMed
  115. Yu H, et al. 2011. J Leukoc Biol. 90:205. PubMed
  116. Doll K, et al. 2016. J Immunol. 196: 4253 - 4262. PubMed
  117. Liu W, et al. 2016. J Virol. 90: 6085 - 6096. PubMed
  118. Fucikova J, et al. 2016. Blood. 128(26):3113-3124. PubMed
  119. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  120. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
  121. Li H, et al. 2012. J Immunol. 189:5572. PubMed
  122. Liu W, et al. 2010. J Virol. 84:12011. PubMed
  123. Elzey B, et al. 2008. Blood. 111:3684. PubMed
  124. Rialdi A, et al. 2016. Science. 352: aad7993. PubMed
  125. Ries M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006506. PubMed
  126. Codo AC, et al. 2020. Cell Metab. 32:437. PubMed
  127. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  128. Carissimo G, et al. 2019. Life Sci Alliance. 2:e201900298. PubMed
  129. Wang Y, et al. 2020. Sci Adv. 6:eaba5412. PubMed
  130. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  131. Uddin MN, et al. 2022. Brain Behav Immun Health. 26:100563. PubMed
  132. Shenoy AT, et al. 2021. Nat Commun. 12:5834. PubMed
  133. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  134. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  135. Dumaine JE, et al. 2021. Elife. 10:. PubMed
  136. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  137. Jondle CN, et al. 2021. J Virol. 95:e0072621. PubMed
  138. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  139. Tawara I, et al. 2011. Clin Cancer Res. 0.761805556. PubMed
  140. Gross C, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e289. PubMed
  141. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  142. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  143. Orlov M, et al. 2017. PLoS One.. 10.1371/journal.pone.018296. PubMed
  144. Martins M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006529. PubMed
  145. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  146. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  147. Buqué A, et al. 2020. Nat Commun. 3.110416667. PubMed
  148. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  149. Harty N 2011. J Immunol. 186:3836. PubMed
  150. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  151. Lee T, et al. 2013. J Biol Chem. 288:32873. PubMed
  152. Vigano S, et al. 2015. J Virol. 89: 7829-7840. PubMed
  153. Vacaflores A, et al. 2016. PLoS One. 11: 0157175. PubMed
  154. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  155. Kim J, et al. 2016. Nat Immunol. 17:1159-1166. PubMed
  156. Cao Y, et al. 2018. Nat Commun. 2.940972222. PubMed
  157. Emmer BT, et al. 2018. Elife. 7:e38839. PubMed
  158. Yan H, et al. 2020. ACS Appl Mater Interfaces. 12:19324. PubMed
  159. Ji L, et al. 2012. PLoS One. 7:e50909. PubMed
  160. Redfern C, et al. 2006. J Clin Oncol. 24:3107. PubMed
  161. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  162. Castro I, et al. 2016. J Virol. 90: 5280 - 5291. PubMed
  163. Zhang W, et al. 2015. Infect Immun . 83: 3213-3223. PubMed
  164. Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
  165. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  166. Gao Y, et al. 2022. Immunity. 55:1732. PubMed
  167. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  168. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  169. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  170. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  171. Krishnan A, et al. 2020. Am J Pathol. 190:1284. PubMed
  172. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  173. Grace PS, et al. 2021. Front Immunol. 12:679973. PubMed
  174. Ngwenyama N, et al. 2019. JCI Insight. 4:e125527. PubMed
  175. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  176. Butchar J, et al. 2010. Clin Cancer Res. 2.100694444. PubMed
  177. Wang J, et al. 2013. J Virol. 87:4372. PubMed
  178. Nice T, et al. 2016. PLoS One. 12: 1005684. PubMed
  179. Pfeifle R, et al. 2016. Nat Immunol. 18:104-113. PubMed
  180. Li Y, et al. 2021. Vaccines (Basel). 9:. PubMed
  181. Liu W, et al. 2022. Bio Protoc. 12:e4285. PubMed
  182. Ma K, et al. 2022. iScience. 25:104347. PubMed
  183. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  184. Stepanova E, et al. 2021. Microorganisms. 9:. PubMed
  185. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  186. Loeuillard E, et al. 2020. J Clin Invest. 130:5380. PubMed
  187. Molinero L, et al. 2012. Proc Natl Acad Sci U S A. 109:18529. PubMed
  188. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  189. Sekine T, et al. 2020. Cell. 183:158. PubMed
  190. Gogokhia L, et al. 2019. Cell Host Microbe. 25:285. PubMed
  191. Matsushita T, et al. 2015. Rheumatology. 101093/rumatology/kv331. PubMed
  192. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  193. Guo C, et al. 2018. Immunity. 49:842. PubMed
  194. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  195. Rossato C, et al. 2017. Biologicals. 10.1016/j.biologicals.2017.06.007. PubMed
  196. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  197. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  198. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  199. Melacarne A, et al. 2021. Cell Reports. 36(1):109312. PubMed
  200. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  201. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  202. Zenaro E, et al. 2009. J Leukoc Biol. 86:1393. PubMed
  203. Goodridge H, et al. 2009. J Immunol. 182:1146. PubMed
  204. Gnerlich J, et al. 2010. J Immunol. 185:4063. PubMed
  205. Boisvert M, et al. 2010. J Virol. 84:7782. PubMed
  206. Langkjær A, et al. 2012. Clin Immunol. 145:1. PubMed
  207. Rozková D, et al. 2009. Clin Immunol. 131:1. PubMed
  208. Miner M, et al. 2008. Microb Pathog. 45:273. PubMed
  209. Miller M, et al. 2014. Proc Natl Acad Sci U S A. 111:7397. PubMed
  210. Gartlan K, et al. 2015. Blood. 126: 1609-1620. PubMed
  211. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  212. Tse SW, et al. 2021. Mol Ther. 29:2227. PubMed
  213. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  214. Virtakoivu R, et al. 2021. Clin Cancer Res. 27:4205. PubMed
  215. Koschel J, et al. 2021. Cell Death Differ. 28:2257. PubMed
  216. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  217. Bass VL, et al. 2021. Mol Syst Biol. 17:e10127. PubMed
  218. Theisen U, et al. 2020. J Cell Biol. :219. PubMed
  219. Dáňová K, et al. 2017. J Immunol. 198(2):729-740. PubMed
  220. Markey K, et al. 2009. Blood. 113:5644. PubMed
  221. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  222. Beyaz S, et al. 2016. Nat Immunol. 18:184-195. PubMed
  223. Kadivar M, et al. 2016. J Immunol. 197(12):4584-4592. PubMed
  224. Wang J, et al. 2013. J Virol. 87:11262. PubMed
  225. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  226. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  227. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  228. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  229. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  230. Li Z, et al. 2021. JCI Insight. 6:. PubMed
  231. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  232. Mohammadpour H, et al. 2020. JCI Insight. 5:00. PubMed
  233. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  234. Bulati M, et al. 2014. Exp Gerontol. 54:123. PubMed
  235. Zhou G, et al. 2014. J Cell Sci. 127:3916. PubMed
  236. Rist M, et al. 2015. J Virol. 89:703. PubMed
  237. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  238. Landi A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.072. PubMed
  239. Gussarow D, et al. 2021. Front Med (Lausanne). 8:770381. PubMed
  240. Genardi S, et al. 2020. Front Immunol. 11:610010. PubMed
  241. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  242. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  243. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  244. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  245. Rau M, et al. 2016. J Immunol. 196: 97 - 105. PubMed
  246. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  247. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  248. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  249. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  250. Schridde A, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.142. PubMed
  251. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  252. Krishna B, et al. 2016. Sci Rep. 6: 24674. PubMed
  253. Ruland C, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.06.010. PubMed
  254. Ahmadi H,et al. 2017. Inflammopharmacology. . 10.1007/s10787-017-0410-8. PubMed
  255. Li J, et al. 2018. Redox Biol. 0.976388889. PubMed
  256. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  257. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
  258. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
  259. Abshire C, et al. 2016. PLoS Pathog. 12:e1006088. PubMed
  260. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  261. Lu G, et al. 2017. PLoS One. 12:e0178352. PubMed
  262. Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed
  263. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  264. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  265. Carrion B, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  266. Petrova T, et al. 2021. FEBS J. 288:5909. PubMed
  267. Nesterenko PA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account